Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene
about
Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor familyThe complexities of breast cancer desmoplasiaComplete nucleotide and deduced amino acid sequences of human and murine preprocathepsin L. An abundant transcript induced by transformation of fibroblastsSodium phenylacetate enhances the inhibitory effect of dextran derivative on breast cancer cell growth in vitro and in nude miceStromal influences on breast cancer cell growth.TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study.Transforming growth factor beta (TGF-beta) and inflammation in cancer.The Brn-3b POU family transcription factor regulates the cellular growth, proliferation, and anchorage dependence of MCF7 human breast cancer cells.The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells.17-beta-estradiol increases mitogenic activity of medium from cultured preadipocytes of massively obese persons.Loss of B-cell translocation gene 2 expression in estrogen receptor-positive breast cancer predicts tamoxifen resistance.Steroid hormone agonists and antagonists in the treatment of cancer.Expression of neu protein, epidermal growth factor receptor, and transforming growth factor alpha in breast cancer. Correlation with clinicopathologic parameters.Silencing of the TGF-β1 gene increases the immunogenicity of cells from human ovarian carcinoma.Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer.Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapyPrognostic significance of ras/p21 alterations in human ovarian cancer.Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.Characterization of the rat transforming growth factor alpha gene and identification of promoter sequences.Insufficiency of transformation by simian virus 40, polyomavirus, EJ-ras, or v-myc oncogenes for conversion of ethanolamine-responsive mammary cells to ethanolamine-nonresponsive cellsThe Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer MetastasisGrowth factors and the gut.SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells.The TGFβ-miR200-MIG6 pathway orchestrates the EMT-associated kinase switch that induces resistance to EGFR inhibitorsHormone receptor assays: clinical usefulness in the management of carcinoma of the breast.Estrogen and progesterone receptor determinations in breast cancer. Technology, biology and clinical significance.Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk.Cloning and overexpression of TGF-beta 1 cDNA in a mammary adenocarcinoma: in vitro and in vivo effects.Hydrolysis of transforming growth factor-alpha by cell-surface peptidases in vitroHuman breast carcinoma desmoplasia is PDGF initiated.Serum and tissue level of insulin-like growth factor-I (IGF-I) and IGF-I binding proteins as an index of pancreatitis and pancreatic cancer.Medium Chain Triglycerides enhances exercise endurance through the increased mitochondrial biogenesis and metabolism.The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression.The effects of functional polymorphisms in the TGFβ1 gene on nasopharyngeal carcinoma susceptibility.Appearance of malignant phenotype with partial loss of hormone dependency in androgen-dependent Shionogi Carcinoma 115 transfected with hst-1 gene.
P2860
Q24319040-EA2C73DD-8AA9-4975-89F5-8CEA212A15E2Q24542473-95481938-5F92-442E-A0D7-E8A887BEA026Q24561568-DC79BB0D-EFFF-4967-B7BA-3B90061F2203Q28352779-F99371B8-9361-4D27-9845-6659C9DA461FQ33276533-67E58CC4-37C2-40A9-8499-40FE44033536Q33298550-FC826E35-786F-4D7B-A7E4-5095E0160D5CQ33712568-4CC98A07-BB05-4DDB-8B95-755813267B54Q34088539-919117B9-08F5-4151-B983-C791F6EC0B6DQ34513252-0C7A5CC8-F02C-441D-8C3C-8811E93BFA4EQ34574792-0A96C530-78B2-435C-9ED3-0A6D875A22D9Q35051765-149128CA-A936-4C7A-9BE9-D6417C85ACF0Q35309303-5D1E58F5-AF28-4298-9991-0988D2D19095Q35831370-653BF1AB-0893-4D10-95AE-1A0B9F90AFF3Q35890860-25B8E3E5-0EF9-4954-8E80-667F8C89826CQ35984169-9A865264-DBA9-4A65-A9F7-D2F676E37851Q36135815-8BDF98AB-67C7-4D49-B1C5-A479D2A6B001Q36421674-F9484B26-51AE-4DE4-BA5D-D017ED6B8756Q36466179-65F3FE6D-0B03-45EF-AE6F-AD4EB6D2C496Q36708367-C5311299-6BFB-401A-B214-655CCF6B024FQ36872298-6DAA960C-17F0-4C9C-9B13-3229DF76B578Q36985643-EAB1B17E-14CD-45B8-B005-49C866A143B4Q37804849-6B707C3F-E66D-4218-9B4F-FBF54B63A6A4Q38702971-BFC6C2FE-B7E8-4226-AD3C-4611A79A5B62Q38994746-6768B719-4F55-4A80-A5CA-783B8734C5CCQ39318408-38001ADA-AE8C-4AD7-9513-9CDB2F2CFC06Q39639564-E51EEC70-2677-467D-A06D-62E897BF6FDBQ40721771-0C1F9E5E-41D3-4472-A68E-BD3807F5ED31Q41147284-AA862216-B9B2-477C-990C-D9F1A80D1984Q41950768-B82E0570-88E0-4FB7-928A-F290468C6E9CQ46033815-00EB7C82-B9BB-4FC1-B78D-4DA7B8EEE5B6Q48029751-71700360-2628-44D0-B56D-72234E919151Q50114625-A93F4FFA-3B07-4112-A185-24C820EDAF78Q50680033-88990661-79ED-421E-877D-D69B12E3F0FFQ53950325-12D52437-5F41-4C43-911E-15A92309C93BQ54285313-EFE5348E-79F3-4C5E-AE60-0C852EA1FE68
P2860
Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene
description
1987 nî lūn-bûn
@nan
1987 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Activation of growth factor se ...... estradiol or v-Ha-ras oncogene
@ast
Activation of growth factor se ...... estradiol or v-Ha-ras oncogene
@en
Activation of growth factor se ...... estradiol or v-Ha-ras oncogene
@nl
type
label
Activation of growth factor se ...... estradiol or v-Ha-ras oncogene
@ast
Activation of growth factor se ...... estradiol or v-Ha-ras oncogene
@en
Activation of growth factor se ...... estradiol or v-Ha-ras oncogene
@nl
prefLabel
Activation of growth factor se ...... estradiol or v-Ha-ras oncogene
@ast
Activation of growth factor se ...... estradiol or v-Ha-ras oncogene
@en
Activation of growth factor se ...... estradiol or v-Ha-ras oncogene
@nl
P2093
P2860
P356
P1476
Activation of growth factor se ...... estradiol or v-Ha-ras oncogene
@en
P2093
Bronzert D
Dickson RB
Gelmann EP
Lippman ME
P2860
P304
P356
10.1073/PNAS.84.3.837
P407
P577
1987-02-01T00:00:00Z